17 Cost-effectiveness potential of therapeutic drug monitoring for depressed inpatients treated with citalopram by shortening of hospitalization

被引：0
|
作者：
Haji, Ostad E. [1 ]
Mann, K. [1 ]
Dragicevic, A. [1 ]
Mueller, M. J. [2 ]
Boland, K. [3 ]
Rao, M. L. [3 ]
Fric, M. [4 ]
Laux, G. [4 ]
Hiemke, C. [1 ]
机构：
[1] Univ Med Ctr Mainz, Dept Psychiat & Psychotherapy, Mainz, Germany
[2] Psychiat Hosp Marburg & Giessen, Giessen, Germany
[3] Univ Bonn, Dept Psychiat & Psychotherapy, Bonn, Germany
[4] Salzach Inn Klinikum, Kbo, Wasserburg, Germany
来源：
PHARMACOPSYCHIATRY | 2012年 / 45卷 / 06期
关键词：
D O I：
暂无
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
引用
收藏
页码：255 / 255
页数：1
相关论文
共 50 条
  • [41] COST-EFFECTIVENESS OF MONITORING ENDOXIFEN LEVELS IN BREAST CANCER PATIENTS ADJUVANTLY TREATED WITH TAMOXIFEN
    Vreman, R.
    van Nuland, M.
    ten Ham, R. M.
    de Vries-Schultink, A. H.
    Rosing, H.
    Schellens, J. H.
    Beijnen, J. H.
    Hovels, A. M.
    VALUE IN HEALTH, 2018, 21 : S46 - S46
  • [42] POSITIVE IMPACT OF A THERAPEUTIC DRUG-MONITORING PROGRAM ON TOTAL AMINOGLYCOSIDE DOSE AND COST OF HOSPITALIZATION
    CRIST, KD
    NAHATA, MC
    ETY, J
    THERAPEUTIC DRUG MONITORING, 1987, 9 (03) : 306 - 310
  • [43] Cost-effectiveness of monitoring endoxifen levels in breast cancer patients adjuvantly treated with tamoxifen
    van Nuland, M.
    Vreman, R. A.
    ten Ham, R. M. T.
    Schultink, A. H. M. de Vries
    Rosing, H.
    Schellens, J. H. M.
    Beijnen, J. H.
    Hovels, A. M.
    BREAST CANCER RESEARCH AND TREATMENT, 2018, 172 (01) : 143 - 150
  • [44] Therapeutic outcome and cost-effectiveness analysis of patients treated in Groupal methods (group analysis, psychodrama, therapeutic community)
    Vassiliki Villiotou
    Annals of General Psychiatry, 5 (Suppl 1)
  • [45] Cost-effectiveness analysis of genotype screening and therapeutic drug monitoring in patients with inflammatory bowel disease treated with azathioprine therapy: a Chinese healthcare perspective using real-world data
    Zeng, Dayong
    Huang, Xiaoting
    Lin, Shen
    Lin, Rongfang
    Weng, Xiuhua
    Huang, Pinfang
    ANNALS OF TRANSLATIONAL MEDICINE, 2021, 9 (14)
  • [46] Efficacy, safety, and cost-effectiveness of therapeutic drug monitoring (TDM) for TNF inhibitor therapy in rheumatic disease: A systematic review and meta-analysis
    Dong, Wenliang
    Hu, Xiaowen
    Wu, Caiying
    Wang, Gengchen
    Fang, Yi
    Shi, Luwen
    Nie, Xiaoyan
    SEMINARS IN ARTHRITIS AND RHEUMATISM, 2023, 63
  • [47] A Systematic Review on Cost-effectiveness Analyses of Therapeutic Drug Monitoring for Patients with Inflammatory Bowel Disease: From Immunosuppressive to Anti-TNF Therapy
    Yao, Jiaqi
    Jiang, Xinchan
    You, Joyce H. S.
    INFLAMMATORY BOWEL DISEASES, 2021, 27 (02) : 275 - 282
  • [48] ELECTRONIC MONITORING IN CORRECTIONS - ASSESSING COST-EFFECTIVENESS AND THE POTENTIAL FOR WIDENING THE NET OF SOCIAL-CONTROL
    MAINPRIZE, S
    CANADIAN JOURNAL OF CRIMINOLOGY-REVUE CANADIENNE DE CRIMINOLOGIE, 1992, 34 (02): : 161 - 180
  • [49] Quantification of the Potential Impact of Cost-effectiveness Thresholds on Dutch Drug Expenditures Using Retrospective Analysis
    Boersma, Cornelis
    Broere, Adriaan
    Postma, Maarten J.
    VALUE IN HEALTH, 2010, 13 (06) : 853 - 856
  • [50] A Model Based Cost-Effectiveness Analysis of Routine Genotyping for CYP2D6 among Older, Depressed Inpatients Starting Nortriptyline Pharmacotherapy
    Berm, Elizabeth J. J.
    Gout-Zwart, Judith J.
    Luttjeboer, Jos
    Wilffert, Bob
    Postma, Maarten J.
    PLOS ONE, 2016, 11 (12):
12345